In This Section

Behavioral Pharmacology at EB 2009

February 23, 2012

Behavioral Pharmacology at EB 2009


Student / post-doc best poster award winners from the EB '09 meeting

1st place post-doc: Greg T. Collins (University of Michigan)

2nd place post-doc: Jun-Xu Li (University of Texas Health Sciences Center at San Antonio)

1st place graduate student: Robert W. Gould (Wake Forest)

2nd place graduate student: tie between Jennifer B. Dwyer (University of California - Irvine) and Remy Brim (University of Michigan)

 

EB '09 Programs 

Pharmacological Imaging in Behavioral Pharmacology and Drug Development
Chairs: Leonard L. Howell and Mike A. Nader

Pharmacological MRI in awake rats: application for drug discovery and development
Chih-Liang Chin, Abbott Laboratories

Pharmacological MRI studies of the dopaminergic system in rhesus monkeys
Zhiming Zhang, University of Kentucky

Functional neuroimaging and cocaine medication development in nonhuman primates
Leonard L. Howell, Emory Universit

PET studies of stimulant drugs in humans
Joanna S. Fowler, Brookhaven National Laboratorie

Advances in Down Syndrome Neuroscience Research:  Implications for Alzheimer's Disease, Dementias and Other Cognitive Disorders
Chairs:  Tim A. Esbenshade and Alberto Costa

Down syndrome: A genetic disorder in biobehavioral perspective
Lynn Nadel, University of Arizona

Human chromosome 21/Down syndrome gene function: Implications for cognitive development and Alzheimer's disease
Kathleen Gardiner, University of Colorado Denver in Aurora

Structural and functional changes at the synapse associated with Down syndrome and Alzheimer's disease
Craig C. Garner, Stanford University

Evidence for NMDA receptor dysfunction in Down Syndrome:  implications for a potential pharmacotherapy
Alberto Costa, University of Colorado Health Sciences Center

Emerging Approaches to Treatment of Alzheimer's Disease
Chairs:  Randy Strong and Greg A. Gerhardt

Current status of treatment of Alzheimer's and related neurodegenerative diseases
Randy Strong and Greg A. Gerhardt, University of Texas Health Science Center Barshop Institute for Longevity & Aging Studies & University of Kentucky

Understanding angiogenic dysregulation in Alzheimer's disease: opening the door for new therapeutic strategies in AD
Gregory A. Jicha, University of Kentucky

Pathways of amyloid-beta toxicity:  Potential novel targets for intervention in Alzheimer's disease
Veronica Galvan, The Buck Institute for Aging Research

The effect of anti-Aß interventions on tau pathology
Salvatore Oddo, University of Texas Health Science Center, San Antonio

Steroid hormone receptor signaling and Alzheimer's disease
Meharvan Singh, University of North Texas Health Science Center, Fort Worth

The Role of Insulin and Leptin in Drug Addiction and Mood
Chairs:  Charles P. France and Lynette C. Daws 

Insulin, leptin, and food reward
Dianne P. Figlewicz Lattemann, University of Washington Health Science Center

The role of leptin signaling in emotional behavior
Xin-Yun Lu, University of Texas Health Science Center at San Antonio

DAT depends on what you eat: Neurochemical and behavioral effects of amphetamine are dependent on insulin status
Lynette C. Daws, University of Texas Health Science Center at San Antonio

The role of leptin on human body weight regulation, endocrine function, and neurobehavioral outcomes
Gilberto Paz-Filho, University of Miami School of Medicine

Related Files:
Categories:
  • BEH Division

Job Postings